Retrospective Descriptive Analysis of Metformin with Atezolizumab in Advanced Non-Small Cell Lung Cancer in The OAK Trial

被引：10
|
作者：
Pietras, R. [1 ,2 ]
Xu, H. [3 ]
Hu, X. [3 ]
Matheny, C. [3 ]
Sandler, A. [3 ]
Patel, M. [4 ]
机构：
[1] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
[2] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Univ Minnesota, Hematol Oncol Transplant, Minneapolis, MN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
metformin; atezolizumab; NSCLC;
D O I：
10.1016/j.jtho.2018.08.748
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-33
引用
收藏
页码：S538 / S539
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety Analysis of Atezolizumab Monotherapy in Patients With Non-Small Cell Lung Cancer
    Komiya, K.
    Ogusu, S.
    Nakashima, C.
    Nakamura, T.
    Nakatomi, K.
    Sasaki, E.
    Sueoka-Aragane, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S639 - S639
  • [22] DETERRED: Phase II Trial Combining Atezolizumab Concurrently with Chemoradiation Therapy in Locally Advanced Non-Small Cell Lung Cancer
    Lin, S.
    Lin, X.
    Clay, D.
    Yao, L.
    Mok, I.
    Gomez, D.
    Kurie, J.
    Simon, G.
    Blumenschein, G.
    Young, J.
    Phan, S.
    Sandler, A.
    Papadimitrakopoulou, V.
    Heymach, J.
    Tsao, A.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S320 - S321
  • [23] Phase II trial combining atezolizumab concurrently with chemoradiation therapy in locally advanced non-small cell lung cancer.
    Lin, Steven H.
    Lin, Yan
    Mok, Isabel
    Young, Jenean A.
    Phan, See
    Sandler, Alan
    Papadimitrakopoulou, Vassiliki
    Heymach, John
    Tsao, Anne S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Long Overall Survival with Atezolizumab in non-small cell Lung Cancer
    Numberger, Markus
    PNEUMOLOGIE, 2021, 75 (04):
  • [25] Long Overall Survival with Atezolizumab in non-small cell Lung Cancer
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (01)
  • [26] Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis
    Liu, Wenjie
    Huo, Gengwei
    Chen, Peng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [27] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Shimada, M.
    Kitazaki, T.
    Fukuda, M.
    Hashiguchi, K.
    Ogawara, D.
    Yamaguchi, H.
    Tomonaga, N.
    Soda, H.
    Nakamura, Y.
    Kohno, S.
    RESPIROLOGY, 2012, 17 : 80 - 80
  • [28] RETROSPECTIVE ANALYSIS OF PEMETREXED IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
    Kitazaki, Takeshi
    Ogawara, Daiki
    Yamaguchi, Hiroyuki
    Fukuda, Minoru
    Shimada, Midori
    Ikeda, Takaya
    Tomonaga, Nanae
    Soda, Hiroshi
    Nakamura, Yoichi
    Kohno, Shigeru
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S489 - S489
  • [29] The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis
    Zhang, Jianrong
    Wu, Jieyu
    He, Qihua
    Liang, Wenhua
    He, Jianxing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (03) : 389 - +
  • [30] Pembrolizumab toxicity in non-small cell lung cancer: a retrospective analysis
    Keast, Mary
    Button, Mick
    Case, Amy
    Iqbal, Sahar
    Namelo, Clara
    Powell, Ceri
    Powell, James
    Shaw, Paul
    Cox, Samantha
    LUNG CANCER, 2022, 165 : S37 - S38
12345